Analysts Set Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) PT at $17.20

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) has earned an average recommendation of “Moderate Buy” from the six brokerages that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $17.20.

A number of brokerages have commented on SENS. Weiss Ratings cut Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday. Wall Street Zen raised shares of Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Stifel Nicolaus reduced their price objective on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Monday, May 11th. Mizuho dropped their price objective on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, July 15th. Finally, HC Wainwright lowered their target price on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, May 12th.

Institutional Investors Weigh In On Senseonics Holdings, Inc. Common Stock

Several hedge funds have recently bought and sold shares of the stock. J.Safra Asset Management Corp bought a new stake in Senseonics Holdings, Inc. Common Stock during the 2nd quarter valued at approximately $636,000. Kestra Advisory Services LLC bought a new stake in shares of Senseonics Holdings, Inc. Common Stock during the 1st quarter valued at about $68,000. GSK plc bought a new stake in Senseonics Holdings, Inc. Common Stock during the fourth quarter valued at approximately $60,000. The Manufacturers Life Insurance Company bought a new position in Senseonics Holdings, Inc. Common Stock in the 2nd quarter worth $65,000. Finally, State of Wyoming bought a new position in Senseonics Holdings, Inc. Common Stock in the 2nd quarter worth $67,000. 12.36% of the stock is currently owned by institutional investors.

Senseonics Holdings, Inc. Common Stock Trading Up 1.0%

NASDAQ SENS opened at $7.81 on Wednesday. The company has a market cap of $326.46 million, a price-to-earnings ratio of -3.50 and a beta of 1.01. The company has a 50-day moving average of $5.95. The company has a debt-to-equity ratio of 0.62, a current ratio of 6.74 and a quick ratio of 6.40. Senseonics Holdings, Inc. Common Stock has a 12 month low of $4.79 and a 12 month high of $11.58.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last posted its quarterly earnings data on Thursday, August 6th. The company reported ($0.63) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.08). The firm had revenue of $14.48 million for the quarter. Senseonics Holdings, Inc. Common Stock had a negative return on equity of 165.80% and a negative net margin of 225.09%. As a group, analysts forecast that Senseonics Holdings, Inc. Common Stock will post -2.29 earnings per share for the current fiscal year.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.